Yuichi Endo
- Immunology top 0.2%
- Molecular Biology top 10%
- Hematology top 1%
- Epidemiology top 5%
- Genetics top 1%
- Co-authors
- Teizo FujitaMisao MatsushitaMinoru TakahashiMunehiro NakataDaisuke IwakiTaroh KinoshitaJunji TakedaToshio Miyata
- Topics
- Complement system in diseases (57 papers)Invertebrate Immune Response Mechanisms (22 papers)Monoclonal and Polyclonal Antibodies Research (14 papers)
- Cited by
- ImmunologyHematologyNephrology
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Yuichi Endo
108 papers receiving 6.2k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Immunology 4.7k
- Molecular Biology 1.2k
- Hematology 1.1k
- Epidemiology 889
- Genetics 752
Countries citing papers authored by Yuichi Endo
This map shows the geographic impact of Yuichi Endo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichi Endo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichi Endo more than expected).
Fields of papers citing papers by Yuichi Endo
This network shows the impact of papers produced by Yuichi Endo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichi Endo. The network helps show where Yuichi Endo may publish in the future.
Co-authorship network of co-authors of Yuichi Endo
This figure shows the co-authorship network connecting the top 25 collaborators of Yuichi Endo. A scholar is included among the top collaborators of Yuichi Endo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuichi Endo. Yuichi Endo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 59 | |
| 2 | 24 | |
| 3 | 132 | |
| 4 | 11 | |
| 5 | 58 | |
| 6 | 126 | |
| 7 | 12 | |
| 8 | 105 | |
| 9 | 43 | |
| 10 | 67 | |
| 11 | 26 | |
| 12 | 119 | |
| 13 | 80 | |
| 14 | [A role of visiting nurses in providing the terminal patients with their desirable life-discussion regarding the place of death of the patients who were registered for visiting nurse system]. | 1 |
| 15 | 110 | |
| 16 | 264 | |
| 17 | 158 | |
| 18 | 36 | |
| 19 | 18 | |
| 20 | 2 |
About Yuichi Endo
Yuichi Endo is a scholar working on Immunology, Genetics and Hematology, having authored 108 papers that have together received 6.3k indexed citations. Recurring topics across this work include Complement system in diseases (57 papers), Invertebrate Immune Response Mechanisms (22 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). The work is most often cited by research in Immunology (4.7k citations), Hematology (1.1k citations) and Nephrology (653 citations). Yuichi Endo has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Teizo Fujita, Misao Matsushita, Minoru Takahashi, Munehiro Nakata, Daisuke Iwaki, Taroh Kinoshita, Junji Takeda, Toshio Miyata, Teruo Kitani and Yoshiyasu Iida. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.